JPWO2020065613A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020065613A5
JPWO2020065613A5 JP2021517202A JP2021517202A JPWO2020065613A5 JP WO2020065613 A5 JPWO2020065613 A5 JP WO2020065613A5 JP 2021517202 A JP2021517202 A JP 2021517202A JP 2021517202 A JP2021517202 A JP 2021517202A JP WO2020065613 A5 JPWO2020065613 A5 JP WO2020065613A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrazolo
methanone
dimethyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021517202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502424A (ja
JP7482116B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/058240 external-priority patent/WO2020065613A1/en
Publication of JP2022502424A publication Critical patent/JP2022502424A/ja
Publication of JPWO2020065613A5 publication Critical patent/JPWO2020065613A5/ja
Application granted granted Critical
Publication of JP7482116B2 publication Critical patent/JP7482116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021517202A 2018-09-28 2019-09-27 モノアシルグリセロールリパーゼ調節因子 Active JP7482116B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862738600P 2018-09-28 2018-09-28
US62/738,600 2018-09-28
PCT/IB2019/058240 WO2020065613A1 (en) 2018-09-28 2019-09-27 Monoacylglycerol lipase modulators

Publications (3)

Publication Number Publication Date
JP2022502424A JP2022502424A (ja) 2022-01-11
JPWO2020065613A5 true JPWO2020065613A5 (hu) 2022-10-05
JP7482116B2 JP7482116B2 (ja) 2024-05-13

Family

ID=68109428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021517202A Active JP7482116B2 (ja) 2018-09-28 2019-09-27 モノアシルグリセロールリパーゼ調節因子

Country Status (23)

Country Link
US (3) US20200102303A1 (hu)
EP (1) EP3856178A1 (hu)
JP (1) JP7482116B2 (hu)
KR (1) KR20210069080A (hu)
CN (1) CN113164459A (hu)
AU (1) AU2019350624A1 (hu)
BR (1) BR112021005896A2 (hu)
CA (1) CA3111380A1 (hu)
CL (1) CL2021000757A1 (hu)
CO (1) CO2021003944A2 (hu)
CR (1) CR20210153A (hu)
EA (1) EA202190886A1 (hu)
EC (1) ECSP21021381A (hu)
IL (1) IL281812A (hu)
JO (1) JOP20210058A1 (hu)
MA (1) MA53721A (hu)
MX (1) MX2021003737A (hu)
NI (1) NI202100023A (hu)
PE (1) PE20211773A1 (hu)
PH (1) PH12021550659A1 (hu)
SG (1) SG11202102281VA (hu)
TW (1) TW202028198A (hu)
WO (1) WO2020065613A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI644671B (zh) 2013-03-14 2018-12-21 比利時商健生藥品公司 P2x7調節劑
EP3856179A1 (en) 2018-09-28 2021-08-04 Janssen Pharmaceutica N.V. Monoacylglycerol lipase modulators
WO2020065613A1 (en) 2018-09-28 2020-04-02 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
US11839663B2 (en) 2019-09-30 2023-12-12 Janssen Pharmaceutica Nv Radiolabelled MGL pet ligands
CA3176946A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
WO2022150962A1 (en) 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof
AR127955A1 (es) 2021-12-16 2024-03-13 Hoffmann La Roche Nuevos compuestos heterocíclicos
CN115872995A (zh) * 2022-12-27 2023-03-31 上海凌凯医药科技有限公司 一种吡唑并吡啶化合物及一种羧酸衍生物的制备方法

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812462A (en) 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
US4816463A (en) 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
JP3208139B2 (ja) 1990-10-02 2001-09-10 ワーナー−ランバート・コンパニー アンギオテンシン▲ii▼アンタゴニスト
MXPA05000947A (es) 2002-07-25 2005-05-16 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
JP2005537290A (ja) 2002-07-25 2005-12-08 ファルマシア・イタリア・エス・ピー・エー キナーゼ阻害剤として活性なビシクロピラゾール類、その製造方法、およびそれを含有する薬学的組成物
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
FR2857363B1 (fr) 2003-07-10 2007-09-07 Aventis Pharma Sa 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
AR045037A1 (es) 2003-07-10 2005-10-12 Aventis Pharma Sa Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
JP2008510810A (ja) 2004-08-23 2008-04-10 メルク エンド カムパニー インコーポレーテッド 糖尿病の治療または予防のためのジペプチジルペプチダーゼ−iv阻害剤としての縮合トリアゾール誘導体
US20080146612A1 (en) 2005-01-27 2008-06-19 Astrazeneca Ab Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor
US7402596B2 (en) 2005-03-24 2008-07-22 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2006110516A1 (en) 2005-04-11 2006-10-19 Abbott Laboratories Acylhydrazide p2x7 antagonists and uses thereof
US7943617B2 (en) 2006-11-27 2011-05-17 Bristol-Myers Squibb Company Heterobicyclic compounds useful as kinase inhibitors
KR20100023040A (ko) 2007-06-21 2010-03-03 쉐링 코포레이션 폴리사이클릭 구아닌 유도체 및 이의 용도
BRPI0812594A2 (pt) 2007-08-10 2015-06-23 Lundbeck & Co As H Composto ou sal ou hidrato do mesmo, composição farmacêutica, métodos para modulação da atividade de um receptor p2x7, para tratamento de uma condição responsiva á modulação do receptor p2x7 em um paciente, para inibição de morte de células gangliônicas retinais em um paciente, para determinação da presença ou ausência de receptor p2x7 em uma amostra, preparação farmacêutica acondicionada, e, uso de um composto ou sal ou hidrato do mesmo.
FR2921342B1 (fr) 2007-09-20 2010-03-12 Airbus France Carenage aerodynamique arriere inferieur pour dispositif d'accrochage d'un moteur d'aeronef
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
ATE533762T1 (de) 2008-04-22 2011-12-15 Janssen Pharmaceutica Nv Chinolin- oder isochinolinsubstituierte p2x7- antagonisten
WO2010060854A1 (en) 2008-11-25 2010-06-03 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
WO2010066629A2 (en) 2008-12-09 2010-06-17 F. Hoffmann-La Roche Ag Novel azaindoles
BRPI1014874A2 (pt) * 2009-04-22 2016-04-12 Janssen Pharmaceutica Nv piperazinil azetidinil amidas heteroaromáticas e aromáticas como inibidores de monoacilglicerol lipase
ES2590987T3 (es) 2009-04-29 2016-11-24 Glaxo Group Limited Derivados de 5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]pirazina como moduladores de P2X7
GB0907515D0 (en) 2009-04-30 2009-06-10 Glaxo Group Ltd Compounds
US8871760B2 (en) 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
EP2491031B1 (en) 2009-10-23 2013-08-07 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as orexin receptor modulators
WO2011103715A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Task channel antagonists
KR101878888B1 (ko) 2010-04-02 2018-08-17 오게다 에스.에이. 신규한 nk-3 수용체 선택적 길항제 화합물, nk-3 수용체 매개형 질환에 사용되기 위한 의약 조성물 및 방법
CN102844507A (zh) 2010-04-16 2012-12-26 罗德里戈·格拉夫费尔南德斯 用于建筑物的可折叠结构
EP2619204A4 (en) 2010-09-21 2014-08-27 Merck Sharp & Dohme TRIAZOLOPYRAZINONES AS ANTAGONISTS OF P2X7 RECEPTORS
EP2630139A1 (en) 2010-10-22 2013-08-28 Janssen Pharmaceutica, N.V. Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
US9586962B2 (en) 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
US9273947B2 (en) 2012-02-07 2016-03-01 Lg Innotek Co., Ltd. Sensing magnet apparatus for motor
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
AR091112A1 (es) 2012-05-22 2015-01-14 Genentech Inc Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر
PE20150886A1 (es) 2012-10-15 2015-06-04 Epizyme Inc Compuestos de benceno sustituidos
MY189505A (en) 2012-10-16 2022-02-16 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of roryt
TWI646099B (zh) 2012-11-01 2019-01-01 英塞特控股公司 作爲jak抑制劑之三環稠合噻吩衍生物
US9796729B2 (en) 2012-11-23 2017-10-24 Glaxosmithkline Llc Compounds as diacylglycerol acyltransferase inhibitors
BR112015014752B1 (pt) 2012-12-21 2022-07-05 Plexxikon, Inc Compostos e seus uso para modulação de cinase
EP2935217B1 (en) 2012-12-21 2019-02-27 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US9233974B2 (en) 2012-12-21 2016-01-12 Gilead Sciences, Inc. Antiviral compounds
US9561228B2 (en) 2013-02-08 2017-02-07 Celgene Avilomics Research, Inc. ERK inhibitors and uses thereof
NZ710640A (en) 2013-03-06 2019-03-29 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
NO335177B1 (no) 2013-03-06 2014-10-13 Cambi Technology As Fremgangsmåte og anordning for termisk biologisk nedbryting og avvanning av biomasse
LT2970127T (lt) 2013-03-14 2019-02-11 Glaxosmithkline Intellectual Property (No. 2) Limited 2,3-dipakeistieji 1-acil-4-amino-1,2,3,4-tetrahidrochinolino dariniai ir jų panaudojimas kaip bromodomeno inhibitorių
JO3509B1 (ar) 2013-03-14 2020-07-05 Janssen Pharmaceutica Nv معدلات p2x7
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
TWI644671B (zh) 2013-03-14 2018-12-21 比利時商健生藥品公司 P2x7調節劑
SG11201507395PA (en) 2013-03-14 2015-10-29 Curadev Pharma Private Ltd Inhibitors of the kynurenine pathway
MX361375B (es) 2013-03-14 2018-12-05 Newlink Genetics Corp Compuestos triciclicos como inhibidores de la inmunosupresion mediada por el metabolismo del triptofano.
TW201522307A (zh) 2013-03-14 2015-06-16 百靈佳殷格翰國際股份有限公司 經取代2-氮雜-雙環[2.2.1]庚烷-3-羧酸(苄基-氰基-甲基)-醯胺組織蛋白酶c抑制劑
ES2689526T3 (es) 2013-03-14 2018-11-14 Janssen Pharmaceutica Nv Moduladores de P2X7
JO3383B1 (ar) 2013-03-14 2019-03-13 Lilly Co Eli مثبطات cdc7
EP3321266A1 (en) 2013-03-14 2018-05-16 Janssen Pharmaceutica NV P2x7 modulators
CA2907814C (en) 2013-03-29 2021-07-13 Euroscreen Sa Novel n-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor-mediated disorders
RU2016110021A (ru) 2013-08-22 2017-09-27 Ф. Хоффманн-Ля Рош Аг Алкиниловые спирты и способы их применения
BR112017004742B1 (pt) 2014-09-11 2022-11-29 Janssen Pharmaceutica Nv 2-azabiciclos substituídos e seu uso como moduladores de receptor de orexina
EA201790600A1 (ru) 2014-09-12 2017-07-31 Янссен Фармацевтика Нв Модулирующие p2x7 n-ацил-триазолопиразины
EP3191492B1 (en) 2014-09-12 2019-01-09 Janssen Pharmaceutica NV P2x7 modulators
US10385057B2 (en) 2015-11-20 2019-08-20 Lundbeck La Jolla Research Center, Inc. Pyrazole compounds and methods of making and using same
EP3856179A1 (en) 2018-09-28 2021-08-04 Janssen Pharmaceutica N.V. Monoacylglycerol lipase modulators
WO2020065613A1 (en) 2018-09-28 2020-04-02 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
CN112272670B (zh) 2019-04-16 2023-12-12 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
US11839663B2 (en) 2019-09-30 2023-12-12 Janssen Pharmaceutica Nv Radiolabelled MGL pet ligands
CA3176946A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators

Similar Documents

Publication Publication Date Title
RU2018112230A (ru) Бициклические соединения в качестве ингибиторов atx
JP2021503004A5 (hu)
JP7482116B2 (ja) モノアシルグリセロールリパーゼ調節因子
KR101862327B1 (ko) 피리돈 및 아자-피리돈 화합물 및 사용 방법
JP2015504057A5 (hu)
JP2016504363A5 (hu)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
HRP20120105T1 (hr) Aminoheterociklički spojevi
WO2015171527A1 (en) Pyrazolopyridine pyrazolopyrimidine and related compounds
KR20140059195A (ko) 트리시클릭 헤테로시클릭 화합물 및 jak 저해제
RU2014102962A (ru) Новые соединения-ингибиторы фосфодиэстеразы типа 10а
KR20150002573A (ko) 벤조티아졸-6-일 아세트산 유도체 및 hiv 감염을 치료하기 위한 이의 용도
US20220289753A1 (en) Shp2 inhibitors
KR20140121482A (ko) 척수성 근위축증을 치료하기 위한 화합물
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
JP2014506929A5 (hu)
JP2014528482A5 (hu)
US20240059703A1 (en) Heterocyclic spiro compounds and methods of use
KR20230079003A (ko) 안드로겐 수용체 조절제로서의 인돌 화합물
US20240109900A1 (en) Azabicyclic shp2 inhibitors
JPWO2020065613A5 (hu)
KR20230107291A (ko) PPARγ 조절제 및 사용 방법
JPWO2020065614A5 (hu)
JPWO2020252353A5 (hu)
JP2023548657A (ja) がんの処置に使用するための、egfrおよび/またはher2のヘテロ環阻害剤